PDXK | Pyridoxal (pyridoxine, vitamin B6) kinase | Enzymes FDA approved drug targets Plasma proteins
| ![](/images/30196/ihc_selected_60x60.jpg) | | | ![](/images/30196/65230_B_5_2_rna_selected_60x60.jpg) | Expressed in all |
PLIN3 | Perilipin 3 | FDA approved drug targets Plasma proteins
| | | | ![](/images/6427/18235_B_7_8_rna_selected_60x60.jpg) | Expressed in all |
PNP | Purine nucleoside phosphorylase | Cytoskeleton related proteins Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| ![](/images/1625/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | | ![](/images/1625/7078_B_9_4_rna_selected_60x60.jpg) | Expressed in all |
PRDX5 | Peroxiredoxin 5 | Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins
| | | | ![](/images/8661/22812_B_9_1_rna_selected_60x60.jpg) | Expressed in all |
PRKAB1 | Protein kinase, AMP-activated, beta 1 non-catalytic subunit | FDA approved drug targets
| | | | ![](/images/5058/13154_B_7_2_rna_selected_60x60.jpg) | Expressed in all |
PSMB1 | Proteasome (prosome, macropain) subunit, beta type, 1 | Enzymes FDA approved drug targets Plasma proteins
| | | | ![](/images/29635/64707_B_9_3_rna_selected_60x60.jpg) | Expressed in all |
PSMB8 | Proteasome (prosome, macropain) subunit, beta type, 8 | Disease related genes Enzymes FDA approved drug targets Plasma proteins
| | ![](/images/46995/if_selected_60x60.jpg) | | ![](/images/50327/118546_B_9_4_rna_selected_60x60.jpg) | Expressed in all |
PSMD1 | Proteasome (prosome, macropain) 26S subunit, non-ATPase, 1 | FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | ![](/images/36736/if_selected_60x60.jpg) | | ![](/images/36737/126709_B_9_6_rna_selected_60x60.jpg) | Expressed in all |
PSMD2 | Proteasome (prosome, macropain) 26S subunit, non-ATPase, 2 | FDA approved drug targets Plasma proteins Predicted membrane proteins
| | ![](/images/45192/if_selected_60x60.jpg) | | ![](/images/45192/100075_B_8_1_rna_selected_60x60.jpg) | Expressed in all |
QPRT | Quinolinate phosphoribosyltransferase | Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| ![](/images/11887/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | | ![](/images/11887/29436_B_9_4_rna_selected_60x60.jpg) | Expressed in all |
RPL3 | Ribosomal protein L3 | FDA approved drug targets Plasma proteins Predicted secreted proteins Ribosomal proteins
| | | | ![](/images/3365/10512_B_8_7_rna_selected_60x60.jpg) | Expressed in all |
RRM2B | Ribonucleotide reductase M2 B (TP53 inducible) | Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins
| ![](/images/28812/ihc_selected_60x60.jpg) | | | ![](/images/6854/16395_B_7_5_rna_selected_60x60.jpg) | Expressed in all |
SHMT1 | Serine hydroxymethyltransferase 1 (soluble) | Enzymes FDA approved drug targets Plasma proteins
| | | | ![](/images/23314/50752_B_8_1_rna_selected_60x60.jpg) | Expressed in all |
SIGMAR1 | Sigma non-opioid intracellular receptor 1 | Disease related genes FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | | ![](/images/13470/31433_B_3_4_rna_selected_60x60.jpg) | Expressed in all |
SIRT5 | Sirtuin 5 | FDA approved drug targets
| | | | ![](/images/22992/50336_B_8_5_rna_selected_60x60.jpg) | Expressed in all |
SOAT1 | Sterol O-acyltransferase 1 | Enzymes FDA approved drug targets Predicted membrane proteins
| | | | ![](/images/47171/146636_B_8_3_rna_selected_60x60.jpg) | Tissue enriched |
SRC | V-src avian sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog | Cancer-related genes Cytoskeleton related proteins Disease related genes Enzymes FDA approved drug targets Plasma proteins
| ![](/images/30875/ihc_selected_60x60.jpg) | | | ![](/images/4023/11916_B_8_2_rna_selected_60x60.jpg) | Mixed |
SV2A | Synaptic vesicle glycoprotein 2A | FDA approved drug targets Predicted membrane proteins
| | | | ![](/images/2226/6002_B_9_2_rna_selected_60x60.jpg) | Tissue enriched |
TNFRSF8 | Tumor necrosis factor receptor superfamily, member 8 | Cancer-related genes CD markers FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | | ![](/images/16/318_B_7_6_rna_selected_60x60.jpg) | Mixed |
TOP1 | Topoisomerase (DNA) I | Cancer-related genes Disease related genes Enzymes FDA approved drug targets
| | | | ![](/images/19039/43951_B_9_2_rna_selected_60x60.jpg) | Expressed in all |
TOP2A | Topoisomerase (DNA) II alpha 170kDa | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins
| | | | ![](/images/2448/6155_B_7_8_rna_selected_60x60.jpg) | Tissue enhanced |
TOP2B | Topoisomerase (DNA) II beta 180kDa | Enzymes FDA approved drug targets Plasma proteins
| | | | ![](/images/4601/11582_B_2_2_rna_selected_60x60.jpg) | Expressed in all |
TUBA1A | Tubulin, alpha 1a | Cancer-related genes Disease related genes FDA approved drug targets
| | ![](/images_static/na_center.gif) | | ![](/images/8686/23064_B_8_1_rna_selected_60x60.jpg) | Expressed in all |
TUBB | Tubulin, beta class I | Cytoskeleton related proteins FDA approved drug targets Plasma proteins
| | ![](/images_static/na_center.gif) | | ![](/images/5417/19721_A_4_6_rna_selected_60x60.jpg) | Expressed in all |
TUBG1 | Tubulin, gamma 1 | Disease related genes FDA approved drug targets Plasma proteins
| | ![](/images_static/na_center.gif) | | ![](/images/4608/11364_B_9_4_rna_selected_60x60.jpg) | Expressed in all |
TXNRD1 | Thioredoxin reductase 1 | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins
| | | | ![](/images/15834/34861_B_1_4_rna_selected_60x60.jpg) | Expressed in all |
TYR | Tyrosinase | Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins
| | ![](/images_static/na_center.gif) | | ![](/images/79/902_B_4_3_rna_selected_60x60.jpg) | Tissue enriched |